Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypothalamus | 14 | 2026 | 135 | 2.450 |
Why?
|
| Obesity | 17 | 2025 | 1279 | 2.320 |
Why?
|
| Adipose Tissue, Brown | 12 | 2026 | 126 | 2.250 |
Why?
|
| Thermogenesis | 8 | 2025 | 128 | 1.900 |
Why?
|
| Eating | 7 | 2020 | 140 | 1.660 |
Why?
|
| Natriuretic Peptides | 3 | 2019 | 9 | 1.600 |
Why?
|
| Receptors, Opioid, kappa | 5 | 2024 | 8 | 1.320 |
Why?
|
| Signal Transduction | 10 | 2026 | 3171 | 1.170 |
Why?
|
| Leptin | 5 | 2024 | 87 | 0.910 |
Why?
|
| Muscle, Skeletal | 4 | 2026 | 788 | 0.910 |
Why?
|
| Interleukin-15 | 1 | 2024 | 25 | 0.840 |
Why?
|
| Body Weight | 5 | 2024 | 376 | 0.830 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 29 | 0.810 |
Why?
|
| Energy Metabolism | 9 | 2024 | 396 | 0.770 |
Why?
|
| Narcotic Antagonists | 2 | 2024 | 134 | 0.750 |
Why?
|
| Sulfonamides | 1 | 2024 | 135 | 0.750 |
Why?
|
| Animals | 39 | 2026 | 21494 | 0.680 |
Why?
|
| Mice | 27 | 2026 | 11183 | 0.640 |
Why?
|
| Receptor, Cannabinoid, CB1 | 2 | 2017 | 15 | 0.630 |
Why?
|
| Guanylyl Cyclase C Agonists | 1 | 2020 | 1 | 0.620 |
Why?
|
| Receptors, Enterotoxin | 1 | 2020 | 6 | 0.620 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 95 | 0.620 |
Why?
|
| Liver | 7 | 2026 | 879 | 0.600 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 133 | 0.590 |
Why?
|
| Rats | 12 | 2024 | 2005 | 0.570 |
Why?
|
| Dopamine | 1 | 2019 | 108 | 0.570 |
Why?
|
| Puberty | 1 | 2018 | 59 | 0.550 |
Why?
|
| Weight Gain | 4 | 2023 | 165 | 0.540 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2017 | 4 | 0.530 |
Why?
|
| Fibroblast Growth Factors | 4 | 2026 | 77 | 0.530 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 430 | 0.520 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 3 | 2026 | 86 | 0.520 |
Why?
|
| Exercise | 1 | 2024 | 970 | 0.510 |
Why?
|
| Diet | 4 | 2024 | 540 | 0.460 |
Why?
|
| Peptides | 1 | 2020 | 593 | 0.460 |
Why?
|
| Mice, Knockout | 9 | 2026 | 2170 | 0.450 |
Why?
|
| Male | 29 | 2026 | 31435 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 13 | 2026 | 3507 | 0.420 |
Why?
|
| Hypothalamic Hormones | 3 | 2019 | 4 | 0.410 |
Why?
|
| Pituitary Hormones | 3 | 2019 | 7 | 0.410 |
Why?
|
| Melanins | 3 | 2019 | 24 | 0.410 |
Why?
|
| DNA-Binding Proteins | 2 | 2017 | 1226 | 0.400 |
Why?
|
| Adipose Tissue, White | 4 | 2024 | 93 | 0.400 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 254 | 0.390 |
Why?
|
| Adiposity | 3 | 2019 | 89 | 0.390 |
Why?
|
| Ependymoglial Cells | 2 | 2024 | 3 | 0.390 |
Why?
|
| Gastric Mucosa | 4 | 2017 | 53 | 0.370 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2019 | 626 | 0.370 |
Why?
|
| Brain | 3 | 2022 | 1672 | 0.360 |
Why?
|
| MAP Kinase Signaling System | 3 | 2024 | 235 | 0.360 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2024 | 149 | 0.360 |
Why?
|
| Insulin Resistance | 3 | 2026 | 410 | 0.350 |
Why?
|
| Sirtuin 1 | 2 | 2022 | 27 | 0.320 |
Why?
|
| Ghrelin | 4 | 2016 | 18 | 0.320 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2026 | 14 | 0.320 |
Why?
|
| Receptors, Dopamine | 2 | 2024 | 16 | 0.300 |
Why?
|
| Homeostasis | 3 | 2024 | 383 | 0.300 |
Why?
|
| Uncoupling Protein 1 | 3 | 2025 | 51 | 0.300 |
Why?
|
| Neurons | 3 | 2026 | 934 | 0.280 |
Why?
|
| Weight Loss | 3 | 2024 | 276 | 0.240 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2026 | 7 | 0.240 |
Why?
|
| Hypogonadism | 1 | 2026 | 15 | 0.240 |
Why?
|
| Nutritional Status | 3 | 2016 | 101 | 0.240 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2026 | 88 | 0.230 |
Why?
|
| Phosphorylation | 4 | 2024 | 962 | 0.230 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2026 | 73 | 0.230 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2023 | 84 | 0.230 |
Why?
|
| Mitochondria | 2 | 2026 | 417 | 0.220 |
Why?
|
| Oxyntomodulin | 1 | 2024 | 2 | 0.220 |
Why?
|
| Caveolae | 1 | 2024 | 3 | 0.220 |
Why?
|
| Caveolin 1 | 1 | 2024 | 10 | 0.220 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2024 | 15 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2024 | 10 | 0.210 |
Why?
|
| Pancreas | 2 | 2024 | 153 | 0.210 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2024 | 36 | 0.210 |
Why?
|
| Muscle Strength | 1 | 2024 | 42 | 0.210 |
Why?
|
| Diet, High-Fat | 3 | 2020 | 178 | 0.210 |
Why?
|
| Dopamine Agonists | 1 | 2024 | 22 | 0.200 |
Why?
|
| Rodentia | 1 | 2024 | 20 | 0.200 |
Why?
|
| Mitochondrial Proteins | 1 | 2025 | 110 | 0.200 |
Why?
|
| Bariatric Surgery | 1 | 2024 | 67 | 0.200 |
Why?
|
| Locomotion | 1 | 2024 | 111 | 0.200 |
Why?
|
| Estrogens | 1 | 2024 | 115 | 0.200 |
Why?
|
| Sexual Maturation | 2 | 2026 | 53 | 0.200 |
Why?
|
| Microglia | 1 | 2026 | 254 | 0.190 |
Why?
|
| Pro-Opiomelanocortin | 2 | 2019 | 7 | 0.190 |
Why?
|
| Alcoholism | 1 | 2026 | 329 | 0.190 |
Why?
|
| Ethanol | 1 | 2026 | 333 | 0.180 |
Why?
|
| Hepatocytes | 2 | 2020 | 225 | 0.180 |
Why?
|
| Adipocytes | 1 | 2024 | 276 | 0.180 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2022 | 7 | 0.180 |
Why?
|
| Cell Membrane | 1 | 2024 | 506 | 0.180 |
Why?
|
| Fatty Liver | 1 | 2023 | 115 | 0.180 |
Why?
|
| Malaria, Cerebral | 1 | 2022 | 24 | 0.180 |
Why?
|
| Hypothyroidism | 1 | 2022 | 42 | 0.180 |
Why?
|
| Injections, Intraventricular | 2 | 2019 | 23 | 0.170 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 15 | 0.170 |
Why?
|
| Glucose Intolerance | 2 | 2019 | 90 | 0.170 |
Why?
|
| Glucose | 1 | 2024 | 474 | 0.170 |
Why?
|
| Female | 13 | 2026 | 34459 | 0.170 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2017 | 10 | 0.170 |
Why?
|
| Humans | 17 | 2026 | 65872 | 0.170 |
Why?
|
| Receptors, Cannabinoid | 1 | 2020 | 7 | 0.160 |
Why?
|
| Lysophospholipids | 1 | 2020 | 26 | 0.160 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 46 | 0.160 |
Why?
|
| Macrophages | 1 | 2026 | 1042 | 0.160 |
Why?
|
| Cardiomegaly | 1 | 2020 | 37 | 0.160 |
Why?
|
| ErbB Receptors | 1 | 2021 | 129 | 0.160 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2022 | 154 | 0.160 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 26 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2020 | 46 | 0.160 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 58 | 0.160 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 36 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2022 | 166 | 0.150 |
Why?
|
| Piperidines | 2 | 2017 | 73 | 0.150 |
Why?
|
| Bromocriptine | 1 | 2019 | 3 | 0.150 |
Why?
|
| Hyperphagia | 1 | 2019 | 18 | 0.150 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2019 | 17 | 0.150 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 227 | 0.150 |
Why?
|
| Pyrazoles | 2 | 2017 | 88 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2019 | 14 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 97 | 0.150 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2020 | 162 | 0.150 |
Why?
|
| Mice, Obese | 1 | 2019 | 79 | 0.140 |
Why?
|
| Anti-Obesity Agents | 1 | 2018 | 16 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 70 | 0.140 |
Why?
|
| Nicotine | 1 | 2019 | 118 | 0.140 |
Why?
|
| Myocardium | 1 | 2020 | 301 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2026 | 1635 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2017 | 22 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2020 | 234 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2019 | 903 | 0.130 |
Why?
|
| Neutrophils | 1 | 2020 | 396 | 0.130 |
Why?
|
| Morpholines | 1 | 2017 | 91 | 0.130 |
Why?
|
| Sirolimus | 1 | 2017 | 93 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2018 | 216 | 0.120 |
Why?
|
| Models, Animal | 1 | 2017 | 243 | 0.120 |
Why?
|
| Lipids | 1 | 2019 | 330 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 451 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 314 | 0.120 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 53 | 0.120 |
Why?
|
| Splanchnic Circulation | 1 | 2016 | 16 | 0.120 |
Why?
|
| Growth Hormone | 1 | 2016 | 18 | 0.120 |
Why?
|
| Autonomic Pathways | 1 | 2015 | 2 | 0.120 |
Why?
|
| Efferent Pathways | 1 | 2015 | 9 | 0.120 |
Why?
|
| Defecation | 1 | 2015 | 17 | 0.120 |
Why?
|
| Vagus Nerve | 1 | 2015 | 20 | 0.120 |
Why?
|
| Fibronectins | 1 | 2015 | 44 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 2015 | 35 | 0.110 |
Why?
|
| Peptide Hormones | 1 | 2015 | 8 | 0.110 |
Why?
|
| Anorexia Nervosa | 1 | 2015 | 16 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 2 | 2026 | 47 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2016 | 157 | 0.110 |
Why?
|
| Fasting | 1 | 2015 | 52 | 0.110 |
Why?
|
| Lactation | 1 | 2015 | 77 | 0.110 |
Why?
|
| Testosterone | 1 | 2015 | 128 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 98 | 0.100 |
Why?
|
| Proteome | 1 | 2015 | 153 | 0.100 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2013 | 18 | 0.100 |
Why?
|
| Adolescent | 3 | 2019 | 6371 | 0.100 |
Why?
|
| Conditioning, Operant | 1 | 2013 | 29 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2015 | 302 | 0.090 |
Why?
|
| Heart Failure | 1 | 2020 | 968 | 0.090 |
Why?
|
| Child | 2 | 2019 | 4656 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 266 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1584 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 735 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2026 | 2742 | 0.080 |
Why?
|
| Inflammation | 3 | 2023 | 1196 | 0.070 |
Why?
|
| Insulin | 2 | 2026 | 695 | 0.070 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2026 | 10 | 0.060 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2026 | 33 | 0.060 |
Why?
|
| Median Eminence | 1 | 2026 | 3 | 0.060 |
Why?
|
| Gonads | 1 | 2026 | 18 | 0.060 |
Why?
|
| Kisspeptins | 1 | 2026 | 26 | 0.060 |
Why?
|
| Agouti-Related Protein | 2 | 2018 | 6 | 0.060 |
Why?
|
| Cathelicidins | 1 | 2026 | 11 | 0.060 |
Why?
|
| Adult | 5 | 2026 | 17595 | 0.060 |
Why?
|
| Fertility | 1 | 2026 | 85 | 0.060 |
Why?
|
| Middle Aged | 5 | 2026 | 18518 | 0.060 |
Why?
|
| Acute-Phase Proteins | 1 | 2026 | 35 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 1299 | 0.050 |
Why?
|
| Adiponectin | 1 | 2024 | 37 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2024 | 52 | 0.050 |
Why?
|
| Cannabinoids | 2 | 2016 | 41 | 0.050 |
Why?
|
| Lipid Droplets | 1 | 2024 | 35 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2026 | 423 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2024 | 104 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 2327 | 0.050 |
Why?
|
| Fatty Acid Synthases | 1 | 2023 | 24 | 0.050 |
Why?
|
| Estradiol | 1 | 2024 | 260 | 0.050 |
Why?
|
| Drug Interactions | 2 | 2013 | 126 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 299 | 0.050 |
Why?
|
| Plasmodium berghei | 1 | 2022 | 21 | 0.040 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 34 | 0.040 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2020 | 8 | 0.040 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 16 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2020 | 46 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 25 | 0.040 |
Why?
|
| Neutropenia | 1 | 2020 | 68 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2020 | 130 | 0.040 |
Why?
|
| Cognition | 1 | 2024 | 515 | 0.040 |
Why?
|
| PPAR alpha | 1 | 2020 | 33 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 206 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2020 | 66 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 195 | 0.040 |
Why?
|
| Ganglionic Stimulants | 1 | 2019 | 6 | 0.040 |
Why?
|
| Ideal Body Weight | 1 | 2019 | 1 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 377 | 0.040 |
Why?
|
| Patch-Clamp Techniques | 1 | 2019 | 137 | 0.040 |
Why?
|
| Regeneration | 1 | 2020 | 127 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 198 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 464 | 0.040 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2018 | 5 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 111 | 0.040 |
Why?
|
| Waist Circumference | 1 | 2018 | 48 | 0.030 |
Why?
|
| Hypothalamic Area, Lateral | 1 | 2017 | 6 | 0.030 |
Why?
|
| Appetite Depressants | 1 | 2017 | 6 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 370 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 365 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 1292 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2032 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2192 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 558 | 0.030 |
Why?
|
| Angiopoietin-like Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Body Composition | 1 | 2015 | 155 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1045 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2653 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2016 | 205 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 2090 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2013 | 11 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2013 | 22 | 0.020 |
Why?
|
| Receptors, Ghrelin | 1 | 2013 | 2 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2013 | 27 | 0.020 |
Why?
|
| Orexins | 1 | 2013 | 6 | 0.020 |
Why?
|
| Reinforcement Schedule | 1 | 2013 | 8 | 0.020 |
Why?
|
| Neuropeptide Y | 1 | 2013 | 13 | 0.020 |
Why?
|
| Infusions, Intraventricular | 1 | 2013 | 12 | 0.020 |
Why?
|
| Enkephalins | 1 | 2013 | 20 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1391 | 0.020 |
Why?
|
| Taste | 1 | 2013 | 41 | 0.020 |
Why?
|
| Microinjections | 1 | 2013 | 68 | 0.020 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 38 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2015 | 502 | 0.020 |
Why?
|
| Protein Precursors | 1 | 2013 | 85 | 0.020 |
Why?
|
| Neuropeptides | 1 | 2013 | 81 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 606 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 901 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 859 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1595 | 0.020 |
Why?
|
| Dependovirus | 1 | 2017 | 760 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 345 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 858 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 347 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 441 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5832 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 3780 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 4887 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 15155 | 0.010 |
Why?
|